Te FDA Advisory Panel has recommended Orlistat for approval. This drug prevents the body from absorbing as much as 30 percent of fat intake. It inhibits enzymes the body releases from breaking down and absorbing fat. There are consequences. If the fat is eaten and not absorbe, it must be eliminated.
Diarrhea can be significant.
This can be a concern if too little of these nutrients are absorbed. Medication should be reserved for the truly obese patient.